Relichem Pharma Private Limited
About Relichem Pharma Private Limited
Data last updated:
Relichem Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the health and beauty retail and distribution segment of the consumer goods sector. It was incorporated on 13 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2012PTC235716.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹1.82 Cr. It is led by directors including Rohitash Kailashchand Mandhana and Rajendrakumar Satyanarayan Holani.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 411 Atlanta Estate G.M. Link Road Near Virwani W.E.Highway Goregaon (East), Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2019, the company reported a revenue of ₹13,846. For the same year it recorded a net loss of ₹2,284 (net margin -16.5%) and EBITDA of -₹2,284 (EBITDA margin -16.5%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address411 Atlanta Estate G.M. Link Road Near Virwani W.E.Highway Goregaon (East), Mumbai, Maharashtra, India – 400063
- IndustryConsumer Goods, Health & Beauty Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Relichem Pharma Private Limited
The main business activity of Relichem Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Relichem Pharma Private Limited FY 2019 filings available
Relichem Pharma Private Limited reported revenue of ₹13,846 for FY 2019.
Financial Statement Summary of Relichem Pharma Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹13,846 | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2,284 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2,284 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Relichem Pharma Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -16.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -16.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Relichem Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Relichem Pharma Private Limited
Relichem Pharma Private Limited is compared with the companies closest to it by revenue in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avali International Private Limited | ₹14,585 (FY 2022) | •••• | •••• | -34.0% | •••• | Tirupur, Tamil Nadu, India |
| Relitick Industries Private Limited | ₹14,396 (FY 2024) | •••• | •••• | -75.0% | •••• | Hoshiarpur, Punjab, India |
| Jolen International Limited | ₹14,164 (FY 2025) | •••• | •••• | -94.0% | •••• | Delhi, India |
| Agarwal Herbals & Cosmetics Private Limited | ₹14,000 (FY 2024) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Phantom Resources Private Limited | ₹13,945 (FY 2021) | •••• | •••• | -100.0% | •••• | Mumbai, Maharashtra, India |
| Relichem Pharma Private Limited this company | ₹13,846 (FY 2019) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Karnal Pharma Park Private Limited | ₹13,808 (FY 2024) | •••• | •••• | •••• | Karnal, Haryana, India | |
| L'amar Lifesciences & Biotech Private Limited | ₹13,711 (FY 2025) | •••• | •••• | 61.0% | •••• | Mumbai, Maharashtra, India |
| Zowie Health Care Private Limited (OPC) | ₹13,676 (FY 2022) | •••• | •••• | -84.0% | •••• | Greater Noida, Uttar Pradesh, India |
| Gianra International Private Limited | ₹13,360 (FY 2025) | •••• | •••• | 201.0% | •••• | Haryana, India |
| LV Beautyworks Solutions Private Limited | ₹13,172 (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Relichem Pharma by revenue in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Relichem Pharma Private Limited
Relichem Pharma Private Limited is audited by KHANDELWAL PRAKASH MURARI BHANDARI & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KHANDELWAL PRAKASH MURARI BHANDARI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Relichem Pharma Private Limited
Relichem Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendrakumar Satyanarayan Holani | Additional Director | 10 Jan 2017 | 9 Years 8 Months | Current |
| Suresh Chand Mandhana Also directs: Chemserves Pharma Private Limited, A-Mark Pharma Private Limited | Additional Director | 27 Feb 2015 | 11 Years 7 Months | Current |
| Rohitash Kailashchand Mandhana Also directs: Chemserves Pharma Private Limited | Director | 13 Sep 2012 | 14 Years 0 Months | Current |
Ownership and Shareholding of Relichem Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Relichem Pharma Private Limited
Relichem Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Relichem Pharma Private Limited
Employment history and EPFO contributions of people linked to Relichem Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Relichem Pharma Private Limited
Relichem Pharma Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Rajendrakumar Satyanarayan Holani was appointed as Additional Director on 10 Jan 2017.
Credit Ratings, Litigation & Regulatory Alerts for Relichem Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Relichem Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Relichem Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Relichem Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Relichem Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Relichem Pharma Private Limited
Relichem Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in health and beauty retail and distribution, within the consumer goods industry. It was incorporated on 13 September 2012 (14+ years old) and is registered under CIN U74120MH2012PTC235716.
Relichem Pharma reported revenue of ₹13,846 for FY 2019.
Relichem Pharma has 3 current directors:
- Rajendrakumar Satyanarayan Holani - Additional Director
- Suresh Chand Mandhana - Additional Director
- Rohitash Kailashchand Mandhana - Director
Relichem Pharma reported a net loss of ₹2,284 (net margin -16.5%) and EBITDA of -₹2,284 (EBITDA margin -16.5%) for FY 2019, as per its filed financial statements.
The CIN (Corporate Identification Number) of Relichem Pharma is U74120MH2012PTC235716. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Relichem Pharma was incorporated on 13 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Relichem Pharma by revenue are Avali International Private Limited, Relitick Industries Private Limited, Jolen International Limited, Agarwal Herbals & Cosmetics Private Limited, Phantom Resources Private Limited and 5 more, all in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharma Retail and Distribution).
Rajendrakumar Satyanarayan Holani was appointed as Additional Director on 10 Jan 2017. Tapan Kumar Kashyap ceased to be Director on 30 Mar 2015. Suresh Chand Mandhana was appointed as Additional Director on 27 Feb 2015. Relichem Pharma has 4 board changes on record in total.
The registered office of Relichem Pharma is at 411 Atlanta Estate G.M. Link Road Near Virwani W.E.Highway Goregaon East, Mumbai, Maharashtra, India – 400063.
Relichem Pharma has an authorised share capital of ₹4 Cr and a paid-up capital of ₹1.82 Cr.
Relichem Pharma operates in the consumer goods industry, in the health and beauty retail and distribution segment.